Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy

BACKGROUND. The objective of this study was to characterize the clinicopathologic features of sicca syndrome associated with immune checkpoint inhibitor (ICI) therapy. SUBJECTS, MATERIALS, AND METHODS. Consecutive patients with new or worsening xerostomia in the setting of ICI treatment for benign o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncologist
Päätekijät: Warner, Blake M., Baer, Alan N., Lipson, Evan J., Allen, Clint, Hinrichs, Christian, Rajan, Arun, Pelayo, Eileen, Beach, Margaret, Gulley, James L., Madan, Ravi A., Feliciano, Josephine, Grisius, Margaret, Long, Lauren, Powers, Astin, Kleiner, David E., Cappelli, Laura, Alevizos, Ilias
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Inc. 2019
Aiheet:
Immuno‐Oncology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738284/
https://ncbi.nlm.nih.gov/pubmed/30996010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0823
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia